EP 2517704 B1 20190501 - PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE AND PREPARATION METHOD THEREOF
Title (en)
PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE AND PREPARATION METHOD THEREOF
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON MORBUS PARKINSON UND ZUBEREITUNGSVERFAHREN DAFÜR
Title (fr)
COMPOSITION PHARMACEUTIQUE DE TRAITEMENT DE LA MALADIE DE PARKINSON ET SA MÉTHODE D'ÉLABORATION
Publication
Application
Priority
CN 2009076069 W 20091225
Abstract (en)
[origin: EP2517704A1] A pharmaceutical composition used to treat Parkinson's disease contains levodopa, carbidopa and entacapone or pharmaceutically acceptable salt thereof, and at least one kind of pharmaceutically acceptable excipients. Entacapone is not mixed with levodopa or carbidopa in the pharmaceutical composition. The preparation method of the pharmaceutical composition includes making the first particles with levodopa and carbidopa, making the second particles with entacapone, and then pressing the two kinds of particles into tablets
IPC 8 full level
A61K 31/277 (2006.01); A61K 9/20 (2006.01); A61K 31/195 (2006.01); A61K 31/198 (2006.01); A61P 25/16 (2006.01)
CPC (source: EP US)
A61K 9/2077 (2013.01 - EP US); A61K 31/195 (2013.01 - EP US); A61K 31/198 (2013.01 - EP US); A61K 31/277 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 25/16 (2017.12 - EP); A61K 9/5084 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
DOCDB simple family (publication)
EP 2517704 A1 20121031; EP 2517704 A4 20140122; EP 2517704 B1 20190501; CN 102781440 A 20121114; CN 102781440 B 20150617; JP 2013515681 A 20130509; JP 5718937 B2 20150513; US 2012276198 A1 20121101; US 9750702 B2 20170905; WO 2011075912 A1 20110630
DOCDB simple family (application)
EP 09852462 A 20091225; CN 2009076069 W 20091225; CN 200980163113 A 20091225; JP 2012545047 A 20091225; US 200913518767 A 20091225